Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
6	3	Search

2026	A systematic review of anticoagulants evaluating efficacy and safety in thromboembolic disease International Journal Of Community Medicine And Public Health Yassir A. Turkistani, Emad Alsaedi, Bader H. Alsawadi, Fawaz M. Almasabi, Fatmah A. Jeddo, Renad K. Alrehaili, Rahaf S. Alrehaily, Mohammed N. Almarwani, Feras S. Beitar, Turki A. Alahmadi, Yara M. Alrehaili, Aljuri H. Almutairi, Abdullah F. Alhejaili
2025	Assessing the knowledge and awareness of community pharmacists toward direct oral anticoagulant therapy in Saudi Arabia: A cross-sectional study Medicine Ahmed Basilim
2025	Detection, isolation, characterization, analytical method development with validation and in-silico analysis of new impurity in rivaroxaban Future Journal of Pharmaceutical Sciences Manohar Reddy Epuru, Jagadam Saroja, Veera Venkata Nanda Kishore Pilli, Ravinder Reddy Vennapureddy
2025	Reduced-Dose Edoxaban in Patients Aged ≥ 80 Years: A Single-Center Real-World Analysis Drugs & Aging Ruiqi Zhang, Jiali Du, Meilin Liu
2023	Evaluation of the inappropriate prescribing practices of rivaroxaban and their association with bleeding in tertiary care hospitals in Saudi Arabia Saudi Journal of Clinical Pharmacy ZekraK Aljehani, KawtherA Salah, RandaM Eldyb, AbdulhadiM Alqahtani, Ohoud Alarfaj, ShereenA Alarfaj, ShereenA Dasuqi
2023	Evaluation of the Inappropriate Prescribing Practices of Rivaroxaban and Their Association with Bleeding in Tertiary Care Hospitals in Saudi Arabia Saudi Journal of Clinical Pharmacy Zekra K. Aljehani, Kawther A. Salah, Randa M. Eldyb, Abdulhadi M. Alqahtani, Ohoud Alarfaj, Shereen A. Dasuqi